Loading…
Ocular involvement in metastatic and systemic malignancies is not rare
Background Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body. Aim The aim of this study is to evaluate the com...
Saved in:
Published in: | Cancer reports 2021-08, Vol.4 (4), p.e1347-n/a |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3 |
container_end_page | n/a |
container_issue | 4 |
container_start_page | e1347 |
container_title | Cancer reports |
container_volume | 4 |
creator | Sthapit, Purnima Rajkarnikar Saiju, Rohit |
description | Background
Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body.
Aim
The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done.
Methods
A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded.
Results
There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients.
Conclusion
Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup. |
doi_str_mv | 10.1002/cnr2.1347 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3876e74752e04e299315a77881bca65c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3876e74752e04e299315a77881bca65c</doaj_id><sourcerecordid>3090225161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</originalsourceid><addsrcrecordid>eNp1kV1LHDEUhkNpqWK96B8oA72pF6v5zsxNoSy1FaRC0etwJnNmm2UmscnMlv33Zl0VLXiVr4eH9-Ql5COjp4xSfuZC4qdMSPOGHHJlxKIWsn77bH9AjnNeU0pZrQVvxHtyIIQSihtxSM6v3DxAqnzYxGGDI4ap7KsRJ8gTTN5VELoqb_OEYzmMMPhVgOA85srnKsSpSpDwA3nXw5Dx-GE9Ijfn36-XPxeXVz8ult8uF04ZbRadFMg1065ThqEEx3toRC8Z65qurxlzFLVuSui-5VxxYQz0sm01NKjaBsURudh7uwhre5v8CGlrI3h7fxHTykIqqQe0ojYajTSKI5XIm0YwBcbUNWsdaOWK6-vedTu3I3aujJ5geCF9-RL8H7uKG1uLIjG0CL48CFL8O2Oe7Oizw2GAgHHOlstaSy0ZZQX9_B-6jnMK5ausoA0tszK9o072lEsx54T9UxhG7a5suyvb7sou7Kfn6Z_Ix2oLcLYH_vkBt6-b7PLXb36vvAPd3bJ2</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3090225161</pqid></control><display><type>article</type><title>Ocular involvement in metastatic and systemic malignancies is not rare</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Wiley-Blackwell Read & Publish Collection</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Sthapit, Purnima Rajkarnikar ; Saiju, Rohit</creator><creatorcontrib>Sthapit, Purnima Rajkarnikar ; Saiju, Rohit</creatorcontrib><description>Background
Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body.
Aim
The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done.
Methods
A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded.
Results
There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients.
Conclusion
Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.</description><identifier>ISSN: 2573-8348</identifier><identifier>EISSN: 2573-8348</identifier><identifier>DOI: 10.1002/cnr2.1347</identifier><identifier>PMID: 33535273</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Adolescent ; Adult ; Age groups ; Aged ; Biopsy ; Breast cancer ; Carcinoma, Bronchogenic - epidemiology ; Carcinoma, Bronchogenic - secondary ; Chemotherapy ; Child ; choroidal metastasis ; Ewings sarcoma ; eye cancer ; Eye Neoplasms - epidemiology ; Eye Neoplasms - secondary ; Eye Neoplasms - therapy ; Female ; Females ; Humans ; Leukemia ; Lung Neoplasms - pathology ; Lymphoma ; Male ; Males ; Metastasis ; Middle Aged ; Multiple myeloma ; Nepal - epidemiology ; ocular malignancy ; ocular metastasis ; Oncology ; orbital metastasis ; Orbital Neoplasms - epidemiology ; Orbital Neoplasms - secondary ; Orbital Neoplasms - therapy ; Original ; Paranasal Sinus Neoplasms - pathology ; Patients ; Retrospective Studies ; Sinuses ; Surgery ; Tumors ; Visual acuity ; Young Adult</subject><ispartof>Cancer reports, 2021-08, Vol.4 (4), p.e1347-n/a</ispartof><rights>2021 The Authors. published by Wiley Periodicals LLC.</rights><rights>2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</citedby><cites>FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</cites><orcidid>0000-0001-5210-7318</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388170/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3090225161?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33535273$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sthapit, Purnima Rajkarnikar</creatorcontrib><creatorcontrib>Saiju, Rohit</creatorcontrib><title>Ocular involvement in metastatic and systemic malignancies is not rare</title><title>Cancer reports</title><addtitle>Cancer Rep (Hoboken)</addtitle><description>Background
Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body.
Aim
The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done.
Methods
A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded.
Results
There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients.
Conclusion
Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age groups</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Breast cancer</subject><subject>Carcinoma, Bronchogenic - epidemiology</subject><subject>Carcinoma, Bronchogenic - secondary</subject><subject>Chemotherapy</subject><subject>Child</subject><subject>choroidal metastasis</subject><subject>Ewings sarcoma</subject><subject>eye cancer</subject><subject>Eye Neoplasms - epidemiology</subject><subject>Eye Neoplasms - secondary</subject><subject>Eye Neoplasms - therapy</subject><subject>Female</subject><subject>Females</subject><subject>Humans</subject><subject>Leukemia</subject><subject>Lung Neoplasms - pathology</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Males</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Multiple myeloma</subject><subject>Nepal - epidemiology</subject><subject>ocular malignancy</subject><subject>ocular metastasis</subject><subject>Oncology</subject><subject>orbital metastasis</subject><subject>Orbital Neoplasms - epidemiology</subject><subject>Orbital Neoplasms - secondary</subject><subject>Orbital Neoplasms - therapy</subject><subject>Original</subject><subject>Paranasal Sinus Neoplasms - pathology</subject><subject>Patients</subject><subject>Retrospective Studies</subject><subject>Sinuses</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Visual acuity</subject><subject>Young Adult</subject><issn>2573-8348</issn><issn>2573-8348</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kV1LHDEUhkNpqWK96B8oA72pF6v5zsxNoSy1FaRC0etwJnNmm2UmscnMlv33Zl0VLXiVr4eH9-Ql5COjp4xSfuZC4qdMSPOGHHJlxKIWsn77bH9AjnNeU0pZrQVvxHtyIIQSihtxSM6v3DxAqnzYxGGDI4ap7KsRJ8gTTN5VELoqb_OEYzmMMPhVgOA85srnKsSpSpDwA3nXw5Dx-GE9Ijfn36-XPxeXVz8ult8uF04ZbRadFMg1065ThqEEx3toRC8Z65qurxlzFLVuSui-5VxxYQz0sm01NKjaBsURudh7uwhre5v8CGlrI3h7fxHTykIqqQe0ojYajTSKI5XIm0YwBcbUNWsdaOWK6-vedTu3I3aujJ5geCF9-RL8H7uKG1uLIjG0CL48CFL8O2Oe7Oizw2GAgHHOlstaSy0ZZQX9_B-6jnMK5ausoA0tszK9o072lEsx54T9UxhG7a5suyvb7sou7Kfn6Z_Ix2oLcLYH_vkBt6-b7PLXb36vvAPd3bJ2</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Sthapit, Purnima Rajkarnikar</creator><creator>Saiju, Rohit</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5210-7318</orcidid></search><sort><creationdate>202108</creationdate><title>Ocular involvement in metastatic and systemic malignancies is not rare</title><author>Sthapit, Purnima Rajkarnikar ; Saiju, Rohit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age groups</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Breast cancer</topic><topic>Carcinoma, Bronchogenic - epidemiology</topic><topic>Carcinoma, Bronchogenic - secondary</topic><topic>Chemotherapy</topic><topic>Child</topic><topic>choroidal metastasis</topic><topic>Ewings sarcoma</topic><topic>eye cancer</topic><topic>Eye Neoplasms - epidemiology</topic><topic>Eye Neoplasms - secondary</topic><topic>Eye Neoplasms - therapy</topic><topic>Female</topic><topic>Females</topic><topic>Humans</topic><topic>Leukemia</topic><topic>Lung Neoplasms - pathology</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Males</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Multiple myeloma</topic><topic>Nepal - epidemiology</topic><topic>ocular malignancy</topic><topic>ocular metastasis</topic><topic>Oncology</topic><topic>orbital metastasis</topic><topic>Orbital Neoplasms - epidemiology</topic><topic>Orbital Neoplasms - secondary</topic><topic>Orbital Neoplasms - therapy</topic><topic>Original</topic><topic>Paranasal Sinus Neoplasms - pathology</topic><topic>Patients</topic><topic>Retrospective Studies</topic><topic>Sinuses</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Visual acuity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sthapit, Purnima Rajkarnikar</creatorcontrib><creatorcontrib>Saiju, Rohit</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Cancer reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sthapit, Purnima Rajkarnikar</au><au>Saiju, Rohit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular involvement in metastatic and systemic malignancies is not rare</atitle><jtitle>Cancer reports</jtitle><addtitle>Cancer Rep (Hoboken)</addtitle><date>2021-08</date><risdate>2021</risdate><volume>4</volume><issue>4</issue><spage>e1347</spage><epage>n/a</epage><pages>e1347-n/a</pages><issn>2573-8348</issn><eissn>2573-8348</eissn><abstract>Background
Metastatic disease to the eye most commonly involves choroid followed by orbit leading to varied ocular manifestations. By comparison, it is relatively rarer than primary malignancies of eye as well as metastasis in other parts of the body.
Aim
The aim of this study is to evaluate the common eye and orbital structures involved in secondary ocular and metastatic disease, to describe its clinical manifestations and outline the management done.
Methods
A retrospective study of newly diagnosed cases of ocular metastasis in last 2 years conducted in our recently established department of ocular oncology at a tertiary eye care hospital in Nepal. Demography, age and sex distribution were noted. The patients were segregated into those with secondary or metastatic ocular malignancies. Detail study on the metastatic disease to eye was made in regards to presenting symptoms, signs, primary site of cancer, and the treatment done. Details of the investigations done, like biopsy and imaging were also recorded.
Results
There were a total of 28 patients, whose age group ranged from 9 years to 69 years with median age of 43 years. Females constituted 46% of total patients. Both the eyes were involved in 9 patients (32%). Eye was secondarily involved by paranasal sinus tumors and Non Hodgkin lymphoma (7 patients each). Ocular metastasis was commonly seen from broncogenic carcinoma in four and breast carcinoma in three patients. Simultaneous metastasis to other parts of the body was also seen in 61% of our patients. Diminution of vision in 49% was the most common presenting feature followed by proptosis in 16% and palpable mass in 14% of patients. Orbit in 43% cases is the commonest ocular structure involved. Histopathologic diagnosis was done in 32% only while rest was based on imaging alone. The most common treatment done was chemotherapy in 57% patients.
Conclusion
Ocular metastasis can display a wide variety of clinical and imaging features and therefore a high degree of suspicion is required. It is often associated with simultaneous metastasis to other parts of the body as well, hence the importance of earlier diagnosis and metastatic workup.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>33535273</pmid><doi>10.1002/cnr2.1347</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-5210-7318</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2573-8348 |
ispartof | Cancer reports, 2021-08, Vol.4 (4), p.e1347-n/a |
issn | 2573-8348 2573-8348 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_3876e74752e04e299315a77881bca65c |
source | Open Access: Wiley-Blackwell Open Access Journals; Wiley-Blackwell Read & Publish Collection; Publicly Available Content (ProQuest); PubMed Central |
subjects | Adolescent Adult Age groups Aged Biopsy Breast cancer Carcinoma, Bronchogenic - epidemiology Carcinoma, Bronchogenic - secondary Chemotherapy Child choroidal metastasis Ewings sarcoma eye cancer Eye Neoplasms - epidemiology Eye Neoplasms - secondary Eye Neoplasms - therapy Female Females Humans Leukemia Lung Neoplasms - pathology Lymphoma Male Males Metastasis Middle Aged Multiple myeloma Nepal - epidemiology ocular malignancy ocular metastasis Oncology orbital metastasis Orbital Neoplasms - epidemiology Orbital Neoplasms - secondary Orbital Neoplasms - therapy Original Paranasal Sinus Neoplasms - pathology Patients Retrospective Studies Sinuses Surgery Tumors Visual acuity Young Adult |
title | Ocular involvement in metastatic and systemic malignancies is not rare |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T08%3A26%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20involvement%20in%20metastatic%20and%20systemic%20malignancies%20is%20not%20rare&rft.jtitle=Cancer%20reports&rft.au=Sthapit,%20Purnima%20Rajkarnikar&rft.date=2021-08&rft.volume=4&rft.issue=4&rft.spage=e1347&rft.epage=n/a&rft.pages=e1347-n/a&rft.issn=2573-8348&rft.eissn=2573-8348&rft_id=info:doi/10.1002/cnr2.1347&rft_dat=%3Cproquest_doaj_%3E3090225161%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5767-d43e2616cd571e4ac2fa93f411d9df811c0e669348fb2252377af4bb6a9e5b9e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3090225161&rft_id=info:pmid/33535273&rfr_iscdi=true |